Tue.Feb 11, 2025

article thumbnail

Judge orders restoration of federal health websites

NPR Health

The pages that are set to be revived include information for patients about HIV testing and HIV prevention medication, guidance on contraceptives and data on adolescent and youth mental health.

article thumbnail

Episode 378 – #IDLove – Staph Bacteremia

The Clinical Problem Solvers

[link] Frameworks discussed in the episode To join us live on Virtual Morning Report (VMR) or to present a case to us, sign up here.

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How the gutting of USAID is reverberating around the world: Worry, despair, praise

NPR Health

Reactions to the changes in USAID run the gamut. Some leading voices like Mexico's president are in favor. Others fear that lives will be lost as health care programs are cut.

86
article thumbnail

Get Up To Speed on Medicare Inflation Rebates: HPM Issues Memorandum Summarizing CMS Final Rule; HPM and Riparian to Co-Host Webinar

FDA Law Blog

By Alan M. Kirschenbaum & Sophia R. Gaulkin Drug manufacturers wont be receiving their first invoices for Medicare Part B and Part D inflation rebates until later this year, but rebates have been accruing since first quarter 2023 for Part B rebates and October 2022 for Part D rebates. To help our readers learn more about these rebates before they confront the first invoices, weve prepared a memo summarizing CMS final rule on the two Medicare inflation rebate programs, which was issued on De

article thumbnail

Canned tuna sold at Costco, Trader Joe's recalled over botulism risk

NPR Health

The voluntary recall covers 13 products sold at major grocery stores in 26 states and the District of Columbia. It was triggered by defective packaging that poses the risk of food poisoning.

IT 78
article thumbnail

FDA Appears to Be Granting Zombie Rare Pediatric Disease Designations Waiting for the Rare Pediatric Disease Priority Review Voucher Program to be Revived

FDA Law Blog

By Mark A. Tobolowsky & Frank J. Sasinowski The rare pediatric disease priority review voucher program remains in its sunsetting state the current authority only allows for granting of such vouchers if the drug was designated as a drug for a rare pediatric disease not later than December 20, 2024, and for which a rare pediatric disease product application is approved not later than September 30, 2026.

IT 59
article thumbnail

Researchers look to genetics to better understand heart disease in South Asians

NPR Health

People of South Asian descent are more likely to be affected by heart disease, but their risks often go unnoticed. Researchers are looking to genetics to learn more and prevent early deaths.

77

More Trending

article thumbnail

9 pieces of advice to help you navigate the ups and downs of romance

NPR Health

Sex and relationship experts share wise words of wisdom on love's thorniest topics, including what to do if a partner cheats and how to talk to your partner about your sex life.

article thumbnail

As measles cases rise, a new book warns parents not to underestimate the disease

NPR Health

As childhood vaccinate rates drop in the U.S. outbreaks of measles are rising. In his new book Booster Shots, Dr. Adam Ratner makes the case that this is a bad sign for public health.

article thumbnail

Abrupt changes to NIH funding rules could disrupt cancer research clinical trials

NPR Health

What's at stake in cancer research as the Trump administration moves to cut "indirect funding" to universities? The immediate past leader of the National Cancer Institute says clinical trials will be disrupted. The Heritage Foundation architect of the plan says universities have been ripping off taxpayers. And 22 state attorneys general are suing to stop the effort.

Clinic 51